Evaluating the Usefulness and Ease of Use of a Next-Generation–Connected Drug Delivery Device for Growth Hormone Therapy: Qualitative Study of Health Care Professionals’ Perceptions

Published on 02.08.2023 in Vol 10 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/46893, first published March 01, 2023.

José I Labarta ^{1, 2} , MD ; Paul Dimitri ³ , BSc, MBChB, PhD ; Matthew Keiser ⁴ , BS, MS ; Ekaterina Koledova ⁵ , MD, PhD ; Octavio Rivera-Romero ⁶ , PhD

¹ Unit of Endocrinology, Department of Pediatrics, Hospital Universitario Miguel Servet, Zaragoza, Spain

² Instituto de Investigación Sanitaria Aragón, Zaragoza, Spain

³ Department of Paediatric Endocrinology, Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom

⁴ Ares Trading SA (an affiliate of Merck KGaA), Eysins, Switzerland

⁵ Global Medical Affairs Cardiometabolic & Endocrinology, Merck Healthcare KGaA, Darmstadt, Germany

⁶ Electronic Technology Department, Universidad de Sevilla, Seville, Spain

Corresponding Author: